Clinical Trial Update: Reanalysis of CVD Risk Factors Via Likelihood Methods

View source ↗

Summary

This trial result update reanalyzes cardiovascular risk factors using likelihood-based methods from completed NHLBI trial data.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atherosclerosis
• Cardiovascular Disease
• Heart Disease

Snippet

Sponsor: National Heart, Lung, and Blood Institute (NHLBI) | Conditions: Cardiovascular Diseases, Heart Diseases | Status: COMPLETED